Find trials
Search tips

A Study to Analyze Metabolic Fingerprinting in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) and Controls

Overview

About this study

The purpose of this study is to perform a comprehensive metabolic fingerprinting of pediatric-adolescents patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) and healthy volunteers.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Male and female subjects, 0 - 18 years of age, inclusive.

Exclusion Criteria:

  • Previous personal or family history of kidney disease.
  • A concomitant systemic disease that may affect the kidney (e.g., lupus, hepatitis B or C, amyloidosis, diabetes mellitus).

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Maria Irazabal Mira, M.D., Ph.D.

Open for enrollment

Contact information:

Maria Irazabal Mira M.D., Ph.D.

(507) 293-3232

IrazabalMira.Maria@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20532369

Mayo Clinic Footer